baber/WOPTO huggingface dataset:
Patent PT-2184241-E (PT)
Title: Method and apparatus for conveying material and ejector apparatus
Inventor: SUNDHOLM GOERAN
IPC: B01D47/10
Filed: 2006-04-13
Abstract: A method for conveying material by applying a pressure difference in a conveying conduit (4), in which method the material is fed into the conveying conduit (4) and in the conveying conduit further into a separating device (5), where the material being conveyed is separated from conveying air, in which method a negative pressure is created in the conveying conduit (4) by means of an ejector apparatus (6), whose suction side is connected to the separating device (5), said ejector apparatus being operated using an operating medium consisting of a liquid mist, especially an aqueous liquid mist, said medium being sprayed through at least one spraying nozzle (122) into an ejector tube (128) directed into a separating element (38). In the method, the generation of the negative pressure to be produced is intensified according to need by limiting the flow of gases, such as air, into the ejector tube (128) from the direction opposite to the spraying direction of its operating medium, i.e. from the outlet end (129) of the ejector tube. The invention also relates to an apparatus and an ejector device.
Patent PT-2723671-E (PT)
Title: Scissor-type lifting table
IPC: B66F7/06
Filed: 2013-08-14
Abstract: A scissor-lift platform comprises a scissor mechanism (1) and scissor elements (3) that are connected to form scissor element pairs by central bearings (2). At least one scissor element (3) of a scissor element pair has a bearing receiving element (4) that is removably connected to the scissor element (3) in order to receive the central bearing (2).
Patent PT-533199-E (PT)
Inventor: HANAI NOBUO
IPC: C07K16/30
Filed: 1992-09-18
Abstract: The present invention discloses a process for the production of humanized chimera antibody, wherein the chimera antibody is produced easily without changing any of the amino acids of its mouse antibody variable region. The invention relates to humanized chimera antibodies obtainable by the claimed process and being reactive with ganglioside GD3, to transformants capable of producing said humanized chimera antibodies, to pharmaceutical compositions comprising said humanized chimera antibodies, and the use of these antibodies for treating cancer.
Patent PT-590530-E (PT)
Inventor: CZECH JOERG
IPC: C12N5/10
Filed: 1993-09-24
Abstract: The invention relates to compounds which contain an antigen binding region which is bound to at least one enzyme which is able to metabolise a compound which has little or no cytotoxicity (prodrug) into a cytotoxic compound (drug), where the antigen binding region consists of a single polypeptide chain. Covalently bonded carbohydrates are advantageously present on the polypeptide chain.
Patent PT-637273-E (PT)
Inventor: MORELLO FREDERICK
IPC: E04B2/86
Filed: 1993-04-21
Abstract: A metal building is formed of adjacent preformed panels of generally U-shape with crimpable edges, the edges of adjacent panels being crimped together to form the building, the building having straight side walls and a continuous arched curved roof in which the side walls are reinforced by similar shaped straight panels positioned against the side walls to form cavities, which cavities may be filled with reinforcing material, electrical conduits and the like.
Patent PT-659187-E (PT)
Inventor: DRAUZ KARLHEINZ
IPC: C07F9/6561
Filed: 1993-09-06
Abstract: PCT No. PCT/EP93/02413 Sec. 371 Date Mar. 10, 1995 Sec. 102(e) Date Mar. 10, 1995 PCT Filed Sep. 6, 1993 PCT Pub. No. WO94/05668 PCT Pub. Date Mar. 17, 1994Compounds of Formula I are disclosed which are useful for controlling undesired vegetation    <IMAGE>  I  wherein Q is    <IMAGE>  Q-1   <IMAGE>  and W, RAm, R4-R8 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula I and a method for controlling undesired vegetation which involves contacting the vegetation or its environment with an effective amount of a compound of Formula I.
Patent PT-667772-E (PT)
Inventor: SUZUKI YUKIO
IPC: C07C227/22
Filed: 1993-11-01
Abstract: Taxane derivatives having an alkyl substituted C13 side-chain.
Patent PT-735868-E (PT)
Inventor: BLOOM ERNEST
IPC: A61P43/00
Filed: 1994-12-08
Abstract: Methods and compositions for preventing or treating non-inflammatory elevated intraocular pressure associated with administered or endogenous steroids including administering to a mammalian organism a composition including (a) an ophthalmologically effective amount of a non-steroidal cyclooxygenase inhibitor, and (b) a pharmaceutically acceptable carrier, to reduce or prevent an elevation of intraocular pressure and/or protein marker induction induced by chronic exposure to glucocorticoids.
Patent PT-777687-E (PT)
Inventor: THIM LARS
IPC: A61K38/22
Filed: 1995-08-25
Abstract: A trefoil (Tr) peptide dimer comprising a single Tr domain is new.
Patent PT-881918-E (PT)
Inventor: GUSEVA MALVINA B
IPC: A61F2/00
Filed: 1996-12-18
Abstract: A synthetic polymeric form of carbon (Tetracarbon(TM)) which exhibits some properties similar to biological tissues. Tetracarbon is highly biocompatible and may have application in medicine and microelectronics. Tetracarbon is a biocompatible substrate coating made by depositing short linear chains of carbon stores upon the surface of the substrate. The carbon chains are non-turbostratic and oriented perpendicular to the substrate surface and are densely packed parallel to one another in hexagonal structures with the distance between the carbon chains being between 4.8-5.03 Å. A layer of Tetracarbon is identical to an adjacent layer and randomly shifted laterally relative to each other.
Patent PT-870014-E (PT)
Title: Aldolase catalytic antibody
Inventor: LERNER RICHARD A
IPC: C12N5/18
Filed: 1996-12-16
Abstract: Antibodies that catalyze the aldol reaction are generated by immunization with a reactive compound that covalently traps a Lysine (Lys) residue in the binding pocket of the antibody by formation of a stable vinylogous amide, i.e., a covalent antibody/hapten complex. The resultant catalytic antibodies employ a catalytic mechanism which mimics the catalytic mechanism employed by natural class I aldolase enzymes.
Patent PT-938576-E (PT)
Inventor: ROOD TRACY A
IPC: A23L7/104
Filed: 1997-11-12
Abstract: The present invention provides a bacterial microorganism having the ability to degrade or detoxify beauvericin or derivatives or analogs of beauvericin. The present invention further provides a method for detoxification of plants pre- or post-harvest using microbes having the ability to degrade or detoxify beauvericin or derivatives or analogs of beauvericin.
Patent PT-979264-E (PT)
Inventor: YAS TANAKA
IPC: C10M133/04
Filed: 1998-04-29
Abstract: A two-stroke motorcycle lubricant comprising a base oil having a viscosity at 100° C. of less than 8 cSt and a pour point below -30° C., preferably below -39° C. The two-stroke motorcycle lubricant further comprises a detergent system based on an ashless, oil-soluble amine. The two-stroke motorcycle lubricant exhibits high levels of cleanliness and low levels of exhaust smoke, whilst maintaining high load carrying capacity. The two-stroke motorcycle lubricant may be dyed.
Patent PT-1013214-E (PT)
IPC: A47J47/18
Filed: 1999-12-07
Abstract: The cleaning bucket has a trolley (7) with side faces (10) which are curved to allow the bucket handles (4) to be folded back parallel to the side faces. The outer sections of the handles have curved sections which extend horizontally (14).
Patent PT-1112473-E (PT)
Inventor: CRONSHAW ANTHONY JAMES
IPC: G01B11/25
Filed: 1999-07-01
Abstract: An apparatus for providing a two-dimensional image of a three-dimensional object illuminates the surface of the object using an illumination source. Portions of the surface are imaged through an aperture in a plate onto a portion of a matrix sensor. The object is rotated about its principle axis while being simultaneously translated, and, at the same time the aperture is also rotated. By synchronizing these translational and rotational movements, successive portions of the object surface can image onto respective successive portions of the matrix sensor, thereby providing an improve two-dimensional image of the surface of the object.
Patent PT-1100774-E (PT)
Inventor: BUCHWALD STEPHEN L
IPC: C07C217/84
Filed: 1999-07-23
Abstract: The present invention provides a method for the preparation of a wide range of primary arylamines. The arylamines are prepared in two efficient, straightforward transformations: 1) an activated aryl group and an imine group are combined, in the presence of a transition metal catalyst, under conditions wherein the transition metal catalyst catalyzes the formation of a carbon-nitrogen bond between the activated carbon of the arene and the imine nitrogen; and 2) the resulting N-aryl imine is transformed, via any of a number of standard protocols, to the primary arylamine. The method of the invention may also be exploited in the preparation of vinylamines.
Patent PT-1128841-E (PT)
Inventor: SCHWARZ HANS-PETER
IPC: A61K38/37
Filed: 1999-11-10
Abstract: The invention relates to a pharmaceutical preparation for treating blood-clotting disorders which is characterized in that it contains at least one protein selected from the group of pro-proteins of the blood clotting and additionally contains a coagulation-physiologically inert receptor binding competitor. The invention also relates to the medical application of said preparation.
Patent SG-61591-G (SG)
Title: Flame-resistant electrical line
IPC: H01B7/295
Filed: 1991-07-26
Abstract: The invention relates to a flame-resistant electric line having a conductor (1) which is surrounded by an insulation (2) over which there is a shielding (3). A ribbon (4) consisting of a glass cloth provided with a metal layer on one side is wound in overlapping manner over the shielding (3). The metal layer is on the outside in the line. The width (B) of the overlap is between 7% and 35% of the width of the ribbon (4). A sheathing (5) of insulating material is arranged over the ribbon (4).
Patent IE-40366-L (IE)
Title: Bis-trifluoromethylimino-imidazolones; pesticides
IPC: A01N47/08
Filed: 1975-01-23
Abstract: Bis-trifluoromethyl-imino-imidazolones of the formula IN WHICH EACH R independently is hydrogen or methyl, R2 is a radical selected from the group consisting of bridged rings; fused rings; directly linearly linked rings; rings linked through oxygen, alkylene, oxyalkylene or alkylenoxyalkylene; and substitution products of any of the foregoing with halogen, alkyl or alkoxy with 1 to 4 carbon atoms; said radicals comprising at least two carbon rings, at least one of which is non-aromatic; R3 is hydrogen or a radical selected from the group consisting of alkyl, alkenyl or alkynyl with up to 8 carbon atoms; substitution products of any of the foregoing with halogen or alkoxy with 1 to 4 carbon atoms; cycloalkyl; cycloalkyl substituted by alkyl with 1 to 4 carbon atoms; aralkyl with up to 4 carbon atoms in the alkyl part; aryl with up to 14 carbon atoms; substitution products of these aralkyl and aryl radicals with halogen, alkyl, haloalkyl or alkoxy with 1 to 4 carbon atoms; and any of the radicals listed under R2; each x independently is an integer from 0 to 4, EACH Y INDEPENDENTLY IS 0 OR 1 EXCEPT THAT Y MUST BE 0 IF X IS 0, AND EACH Z INDEPENDENTLY IS AN INTEGER FROM 0 TO 4, WHICH POSSESS ACARICIDAL, INSECTICIDAL AND FUNGICIDAL PROPERTIES.
[US3971804A]
Patent IE-45296-L (IE)
Title: Surface finishing machines
IPC: B24B31/073
Filed: 1977-01-25
Abstract: Parts or workpieces are surface finished in a vibratory finishing chamber with loose finishing material. The parts or group of parts are isolated from each other by part-isolating means which travel with the material in the finishing chamber. The part-isolating means comprise transverse walls maintained in close proximity to the inner surface of the finishing chamber. Means are provided for bringing at least two transverse walls into closer proximity to the inner surface of the finishing chamber, advantageously, sufficiently close to prevent passage of substantial amounts of loose finishing material from passing between the transverse walls and the inner surface of the finishing chamber.
[US4022012A]
Patent IE-890165-L (IE)
Title: Compositions comprising a polyarylene sulfide resin
IPC: C08L81/02
Filed: 1989-01-19
Abstract: A polyarylene sulfide composition is improved in impact resistance and comprises     (A) 100 parts by weight of a polyarylene sulfide resin and (B) 0.5 to 50 parts by weight of a graft copolymer comprising (a) an olefin copolymer comprising an  alpha -olefin and a glycidyl ester of an  alpha , beta -unsaturated acid and (b) one or more polymers or copolymers constituted of a repeating unit represented by the following general formula (1), both of which are chemically bonded to each other to form a branched or crosslinked structure: <CHEM> wherein R stands for a hydrogen atom or a lower alkyl group and X is an alkyl having 1 to 8 carbon atoms, straight or branched, phenyl or cyano. y
Patent IE-900316-L (IE)
Title: New heparinic derivatives and process for their preparation
IPC: C08B37/10
Filed: 1990-01-29
Abstract: New heparinic derivatives having anticalculous activity, devoid of the anticoagulant and antithrombotic activity characteristic of the heparins, obtained by treating commercial or purified or low molecular ueight heparins in a basic medium, optionally in the presence of alkali metal salts and of a reducing agent. The heparinic derivatives obtained through this treatment show peculiar chemical-physical characteristics, in particular they present a <1><3>C-NMR spectrum different from that of the starting haparins especially in the zone comprised between 102 and 92 p.p.m., with the presence of a characteristic signal at 101.3 p.p.m., a specific rotatory power at 546 nm comprised betueen about +15 DEG and about +40 DEG in aqueous solution, a sulfur content comprised between about 6% and about 9%, a sulfate/carboxyls ratio comprised between about 1.20 and about 1.70 and a content of free amino groups comprised between about 0.4% and about 2.1%. Said heparinic derivatives can be useful in the treatment of the nephrolithiases.
Patent IE-880665-L (IE)
Title: Compositions and methods for treating gastrointestinal¹disorders
IPC: A61P31/04
Filed: 1988-03-08
Abstract: The present invention relates to pharmaceutical compositions useful for treating or preventing gastrointestinal disorders. These compositions comprise a campylobacter-inhibiting antimicrobial agent such as nitrofurantoin and bismuth subsalicylate, and a histamine-2 receptor blocking anti-secretory agent such as cimetidine. The present invention further relates to methods for treating or preventing gastrointestinal disorders in humans or lower animals by administering a campylobacter-inhibiting antimicrobial agent and a histamine-2 receptor blocking anti-secretory agent.
Patent IE-810666-L (IE)
Title: Recovering a starch slurry
IPC: C13B5/00
Filed: 1981-03-25
Abstract: A process for recovering a starch slurry from a starch-bearing material such as corn, potatoes or wheat, is characterized in that water being used in the process is separated, e.g. by reverse osmosis, into two fractions, including a first fraction [permeate] of low solubles and insolubles content which is recycled and used for washing the starch. In Figure 3, water containing gluten from the primary separation station of a corn wet milling process is separated by reverse osmosis into a first fraction which is recycled and used to wash starch, and a second fraction which passes to a gluten concentrator. he separation step reduces the water requirements of the process and reduces the volume of effluent for evaporation or disposal. 
[EP0038130A2]
Patent IE-850724-L (IE)
Title: 6-methyl-3, 4-dihydro-1, 2, 3-oxathiazin-4-one 2, 2-dioxide
IPC: C07D291/06
Filed: 1985-03-21
Abstract: 6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide is prepared by reaction of acetoacetamide with at least approximately twice the molar amount of SO3 per mole of acetoacetamide, if appropriate in an inert inorganic or organic solvent. Relevant salts can be obtained, using bases, from the product which results in the form of the acid. The non-toxic salts, in particular the potassium salt, are valuable synthetic sweeteners.
Patent IE-800859-L (IE)
Title: Propogating hemotropic parasites
IPC: C12N1/10
Filed: 1980-04-28
Abstract: A method for quantitative propagation of hemotropic parasites, especially Babesia parasites, in vitro, Babesia-infected erythrocyte cultures are incubated in an environment of enhanced carbon dioxide tension wherein the culture medium overlay provides a barrier to oxygen transmission such that cellular hemoglobin is essentially maintained in its deoxy state. By varying environmental carbon dioxide tension, merozoite stages of the parasite are selectively reversibly induced to migration between residence in host cells or culture medium, rendering possible the isolation of infective antigenic merozoites in large quantities. Specific Babesia antigen is harvested in large quantity from the in vitro culture medium.
[US4307191A]
Patent FI-851020-L (FI)
Inventor: ZIELS BURTON DAVIS
IPC: B05B12/06
Filed: 1985-03-14
Abstract: A retracting lance tube (12) for a sootblower used to clean the interior of large scale boilers featuring nozzle improvements which produce a more concentrated spray of blowing agent discharge thereby enhancing cleaning performance. According to a first embodiment of this invention, nozzles (160) are employed at various longitudinal positions along the lance tube. According to a seond embodiment, nozzles (14R) located at a particular longitudinal position are offset such that their centerlines do not intersect the lance tube centerline. Each embodiment enables the use of longer more efficient nozzles than is possible according to the prior art.
Patent IE-34509-L (IE)
Title: Pre-vulcanised polymer latices.
IPC: C08J3/26
Filed: 1970-09-07
Abstract: A prevulcanized polymer latex is made by treating an unsaturated polymer in an aqueous medium with hydrogen peroxide and a hydrogen peroxide activator which does not encourage the decomposition of the hydrogen peroxide to produce molecular oxygen under the conditions of the treatment. The prevulcanized polymer latex may be used in latex applications such as in adhesives, coatings, carpet backings, dips, threads, tapes and foams, of which the following is a Specification.
[US3755232A]
Patent IE-851188-L (IE)
Title: Sulphoadenosylmethionine salts
IPC: C07H19/16
Filed: 1985-05-13
Abstract: This invention relates to new stable sulpho-adenosyl-L-methionine (SAMe) salts and the relative production process. Said salts have the following general formula: SAMe.nR(O)m(SO3H)p (I) where m can be zero or 1; n is 1.5 when p is 2, and is 3 when p is 1; R is chosen from the group consisting of alkyl, phenylalkyl and carboxyalkyl, in which the linear or branched alkyl chain contains from 8 to 18 carbon atoms. In particular, the salts according to the present invention are SAMe salts of sulphonic acids, or of sulphuric acid esters, or of dioctylsulphosuccinic acid, which fall within formula (I). The process for producing said salts consists of: a) enriching the starting yeast with SAMe; b) lysing the cells and recovering an aqueous solution rich in SAMe (cell lysate); c) purifying the lysate by ultrafiltration; d) precipitating the SAMe by treatment with one of the aforesaid acids or esters; e) separating the precipitated product, washing it and drying it under vacuum.
Patent IE-861396-L (IE)
Title: Monoclonal antibodies to carcinomas
IPC: G01N33/532
Filed: 1986-05-27
Abstract: The present invention is concerned with two novel monoclonal antibodies which define carbohydrate antigens associated with human non-small cell lung carcinomas («NSCLC») and certain other human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods. The invention also comprises a method for determining the presence of a malignant condition in the lung of a subject. The method involves examining tissue from the subject for the presence of antigens which are Le<sup>x</sup> or Le<sup>Y</sup> antigen or which have the characteristics of Le<sup>Y</sup> and Le<sup>x</sup>.
Patent IE-821510-L (IE)
Title: Soluble liver uricase
IPC: C12N11/06
Filed: 1982-06-24
Abstract: The present invention provides liver uricase, wherein it is covalently bond to a water-soluble polysaccharide, polyacid anhydride, polyvinylpyrrolidone or acid anhydride as carrier substance and is still soluble at pH values below 6. The present invention also provides a process for the preparation of this liver uricase.
Patent IE-33981-L (IE)
Title: Piperazine derivatives
IPC: C07D303/22
Filed: 1969-12-22
Abstract: 1,264,564. Derivatives of 4-phenylpiperidine and 4-phenyltetrahydropyridine. F. HOFFMANN-LA ROCHE & CO. A.G. 16 Dec., 1969 [24 Dec., 1968], No. 61245/69. Heading C2C. The invention comprises compounds of formula and their pharmaceutically acceptable acid addition salts, wherein R 1 is H, NH 2 , NHR, N(R) 2 , R<SP>1</SP>CONH, R<SP>1</SP>CONR, ArCONH, RSO 2 NH, NH 2 CO or NH 2 CONH [R=C 1-6 alkyl, R<SP>1</SP>=C 1-5 alkyl, Ar = (up to C 11 ) haloaryl]; R 2 is H, halogen, R or RO; R 3 is halogen; R 4 is H and R 5 is H or OH, or R 4 -R 5 is a C-C bond; X is O or S; and Y is CH 2 , CO, CHOH, R<SP>1</SP>CO 2 CH, RSO 3 CH or PhSO 3 CH (in which Ph may contain a C 1-4 alkyl group). These compounds are prepared by (1) reacting R 1 R 2 C 6 H 3 XCH 2 YCH 2 Z (where R 1 is H, NO 2 , R<SP>1</SP>CONH, R<SP>1</SP>CONR, ArCONH, NH 2 CO or NH 2 CONH, Z is halogen, RSO 3 or ArSO 3 , or YCH 2 Z is epoxyethyl, and R 2 , X and Y are otherwise as defined above) with the corresponding 4 - halophenyl - hexa (or tetra) hydropyridine; (2) reacting R 1 R 2 C 6 H 2 XH with the corresponding 1-(ZCH 2 YCH 2 )-4- halophenyl-hexa (or tetra) hydropyridine (in which reactants the symbols have the same meaning as in method (1)); (3) reducing the NO 2 group in a product of the above formula where R 1 =NO 2 ; (4) optionally (a) hydrogenating a tetrahydropyridine, (b) saponifying an acylamino group, (c) acylating or alkylating an amino group, (d) reducing a CO group, (e) esterifying a CHOH group, and/or (f) forming a salt. The compounds in which Y is CHOH and/or R 5 is OH may be optically resolved. Therapeutic compositions for oral, parenteral or rectal administration comprise compounds of the above formula, which have antiphlogistic, antiallergic, antitussive and analgesic activity.
[GB1264564A]
Patent IE-40019-L (IE)
Title: 6-trichloroacetamidopenicillanic acid derivatives
IPC: C07D499/00
Filed: 1974-09-05
Abstract: 1454587 6-Trichloroacetamido-penicillanic acid derivatives RHONE-POULENC SA 5 Sept 1974 [6 Sept 1973] 38881/74 Heading C2C The invention comprises compounds of the formula wherein R is an ester radical. They may be obtained by either oxidizing the S-atom of a compound of the formula to a sulphoxide group, with, e.g. H 2 O 2 , NaIO 4 or an organic per-acid; or reacting a compound of the formula wherein R 1 is PhCH 2 or PhOCH 2 , with or a derivative thereof. Compounds of Formula II may be obtained either by reacting a compound of the formula with Cl 3 CCOOH or a derivative thereof or by reacting an imino-chloride of the above compound with an alkali metal salt of Cl 3 CCOOH. Compounds of Formula III may be obtained either by oxidation of a compound of Formula IV or by esterification of a compound of the formula
[GB1454587A]